Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 31 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer

    Jacksonville, FL, Rochester, MN

  2. Changes in Blood Components in Patients with Ovarian Cancer

    Rochester, MN

  3. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  4. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  5. A Study to Evaluate Regulation of the Metabolism of T-Cells by the Tumor Microenvironment in Ovarian Cancer Metastasis

    Scottsdale/Phoenix, AZ

  6. Establishment of Preclinical Models from Patients with Gynecological Malignancies

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC

    Rochester, MN

  8. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  9. Saliva and remote monitoring of active Cytomegalovirus infection and symptoms during ovarian cancer treatment

    Rochester, MN

  10. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer